Drug Pipeline

Ferumoxytol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
6
Recruiting
3
Phase 3
6
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
3
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07518901 Nanozymes in Endodontics Apical Periodontitis Not Yet Recruiting
Phase 3
NCT07461948 Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in… Glioblastoma Recruiting
NCT03619850 A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics… Chronic Kidney Disease; Iron Deficiency Anemia Recruiting
NCT03893045 A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in… Iron Deficiency Anemia Recruiting
Phase 2
NCT03270059 Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central… Central Nervous System Neoplasm Recruiting
NCT06483061 Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy Epilepsy, Temporal Lobe Recruiting
Not specified
NCT07400406 A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified… Coronary Artery Calcification Recruiting
Sponsors Running Ferumoxytol Trials
AMAG Pharmaceuticals, Inc. (2) OHSU Knight Cancer Institute (1) University of Alberta (1) The First Affiliated Hospital with Nanjing Medical University (1) Jonsson Comprehensive Cancer Center (1) University of Pennsylvania (1)
Disease Areas
Chronic Kidney Disease (1) Epilepsy (1) Glioblastoma (1)
Get alerts when Ferumoxytol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free